Lisa Hannusch
About Lisa G. Hannusch
Independent director of Crawford & Company since May 8, 2019 (age 61). She is Managing Member and CEO of Rhino Results, LLC (founded 2017), and previously owned and led UniMed Direct (2004–2017), a medical management software and services firm acquired by Mitchell International in 2017. Her career spans 30+ years in claims services, medical, regulatory, and insurance adjacencies; advisory roles include Cadence Rx (PBM), Bailey Group (private equity), Little Tesoros Therapy Services, and service on the National Board of Governors for the Human Rights Campaign .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Rhino Results, LLC | Managing Member & CEO | “Currently”; founded in 2017 | Strategy consulting and investments in healthcare/insurance-related industries |
| UniMed Direct | Owner & CEO | 2004–2017 | Led medical management software and services; company purchased by Mitchell International in 2017 |
External Roles
| Organization | Role | Type | Notes |
|---|---|---|---|
| Cadence Rx | Advisory Board Member | Private company (PBM) | Advisory capacity |
| Bailey Group | Advisory Board Member | Private equity firm | Advisory capacity |
| Little Tesoros Therapy Services | Advisory Board Member | Pediatric therapy clinics | Advisory capacity |
| Human Rights Campaign | National Board of Governors | Non-profit | National governance role |
Board Governance
| Topic | Detail |
|---|---|
| Independence | Board determined all director nominees independent under NYSE standards except the CEO; Hannusch is independent . |
| Standing Committees | Audit Committee (member); Governance Committee (member) . |
| Committee Chairs | Audit Chair: Fred R. Donner; Governance Chair: Rahul Patel . |
| 2024 Committee Meetings | Audit: 10 meetings; Governance: 4 meetings . |
| Board Meetings & Attendance | Board held 5 meetings in 2024; each current director attended at least 75% of Board and committee meetings of which they were a member . |
| Executive Sessions | Independent directors met 5 times in 2024; presided over by Non-Executive Chair Jesse C. Crawford, Jr. . |
| Related-Party Oversight | Audit Committee reviews/approves related-party transactions per written policy; independence determinations consider any related-party transactions . |
| Leadership Structure | Chair and CEO roles separated; Board believes separation enhances oversight and independence . |
Fixed Compensation
| Element | 2024 Value |
|---|---|
| Annual cash retainer (paid quarterly) | $50,000 |
| Board meeting fees (per meeting) | $1,500 |
| Committee meeting fees (per meeting) | $1,500 |
| Restricted share award (granted annually) | $90,000 |
| Chair retainers (if applicable) | Audit Chair $25,000; Comp & HC Chair $15,000; Governance Chair $12,500; Executive Committee Chair $12,000; Board Chair $100,000 |
| Lisa G. Hannusch – 2024 Director Compensation | Amount |
|---|---|
| Fees earned or paid in cash | $81,500 |
| Stock awards (grant-date fair value, ASC 718) | $89,990 |
| Option awards | — |
| All other compensation | — |
| Total | $171,490 |
| Note | Restricted share awards granted to Directors in 2024 vested in full on December 31, 2024 |
Performance Compensation
| Component | Detail |
|---|---|
| Equity vehicle | Restricted share award (non-employee director) |
| Grant-date fair value (2024) | $89,990 |
| Vesting | Vested in full on December 31, 2024 |
| Performance metrics | None disclosed for director equity; awards are time-based (no PSU/options for directors in 2024) |
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Current public company boards | Not disclosed for Hannusch in the proxy biography (advisory and non-profit roles noted) . |
| Compensation Committee interlocks | The CHC Committee members are Beale (Chair), J. C. Crawford, Murphy, and Donner; interlocks disclosure reports none; Hannusch is not on this committee . |
Expertise & Qualifications
- 30+ years in claims services, medical, regulatory, and insurance-adjacent sectors; founder/operator background (UniMed Direct), and ongoing consulting/investment leadership (Rhino Results) .
- Governance experience via Audit Committee (financial reporting, internal controls, cybersecurity oversight) and Governance Committee (ERM oversight, compliance/ethics, board succession) .
Equity Ownership
| Holder | Class A Shares | Class B Shares | % of Class A Outstanding | % of Class B Outstanding |
|---|---|---|---|---|
| Lisa G. Hannusch | 72,691 | — | <1% | — |
| Stock Ownership Guidelines (Directors) | Status |
|---|---|
| Requirement | $200,000 in value or 25,000 shares (2024) |
| Compliance | All current non-employee directors comply, except Donner (grace to Nov 2, 2025) and Murphy (grace to Jun 25, 2026); implies Hannusch is in compliance |
Governance Assessment
- Independent, experienced operator-investor with sector-relevant expertise; sits on Audit and Governance—two high-impact committees for financial reporting integrity and governance/ERM—supporting board effectiveness .
- Strong engagement signals: Board met 5x; Audit 10x; Governance 4x; independent directors held 5 executive sessions; each current director attended at least 75% of applicable meetings; nominees (except Murphy) attended the 2024 annual meeting, indicating commitment .
- Pay and alignment: 2024 mix balanced between cash ($81.5k) and equity ($89.99k), with full-year vesting and compliance with director ownership guidelines, aligning with shareholders without risk-inducing option grants .
- Conflicts/controls: Audit Committee oversees related-party transactions; Board expressly considered related-party matters in independence determinations; no specific related-party transactions involving Hannusch are disclosed in the cited sections .
- Structural context: Separation of Chair/CEO is a positive governance feature; however, the company remains controlled by the Crawford family (e.g., Jesse C. Crawford owns 67.7% of Class B), a factor investors should monitor for potential minority-shareholder risk despite independent oversight .
- Compliance hygiene: The company reports timely Section 16(a) beneficial ownership filings by officers/directors and >10% holders for 2024, reducing procedural red-flag risk .